bioRxiv Science⌕ Search

Biology subjects

Capitano, M. L.

Publications and source records attributed to Capitano, M. L..

2 recordsLinked to original sources

Local Oxygen Tension Dictates Hematopoietic Cell Growth and Potency

Hematopoietic stem and progenitor cells support a lifetime supply of blood and immune cells, can become neoplastic when dysregulated, and constitute a powerful cell therapy vehicle for hematologic diseases. Here we provide the most comprehensive study of hematopoietic oxygen (O2) dependency to date, demonstrating that human hematopoietic cell numbers, growth, biochemical properties, and functional potency is affected by variation in physiologically and clinically relevant local O2 tensions. Lineage defined progenitor cells showed increased expansion in high oxygen, while primitive cells and those with in vivo potency were maintained at higher frequencies in low physiologic O2. We also present a novel hematopoietic cell oxygen-dependent single cell transcriptomic profile. This and biochemical validation revealed that low O2 preserves cells with lower metabolic activity in a less proliferative state that exhibit decreased accumulation of stress markers. Transcriptomics and mouse modeling also elucidated oxygen-dependent mRNA markers of hematopoietic potency. These data reveal oxygen-sensing pathways as targets to improve hematopoietic cell therapies and suggest that local O2 tension dictates hematopoietic potential in anatomic niches.

cell biology↗

Mutant p53 Drives Clonal Hematopoiesis through Modulating Epigenetic Pathway

Clonal hematopoiesis of indeterminate potential (CHIP) increases with age and is associated with increased risks of hematological malignancies. While TP53 mutations have been identified in CHIP, the molecular mechanisms by which mutant p53 promotes hematopoietic stem and progenitor cell (HSPC) expansion are largely unknown. We discovered that mutant p53 confers a competitive advantage to HSPCs following transplantation and promotes HSPC expansion after radiation-induced stress. Mechanistically, mutant p53 interacts with EZH2 and enhances its association with the chromatin, thereby increasing the levels of H3K27me3 in genes regulating HSPC self-renewal and differentiation. Further, genetic and pharmacological inhibition of EZH2 decrease the repopulating potential of p53 mutant HSPCs. Thus, we have uncovered an epigenetic mechanism by which mutant p53 drives clonal hematopoiesis. Our work will likely establish epigenetic regulator EZH2 as a novel therapeutic target for preventing CHIP progression and treating hematological malignancies with TP53 mutations.

cancer biology↗